FOXO Technologies Inc. FOXO
At closeOct 30, 2026, 4:00 PM EDT
After hours · Oct 30, 4:00 PM ET
- YTD
- -66.67%
- 1 year
- -95.83%
- Market cap
- 165.81K
- Revenue (ttm)
- 155.00K
- EPS (ttm)
- 1,410.07
- Shares out
- 17.48M
- P/E ratio
- 0.00
- YTD return
- -66.67%
- 1-year return
- -95.83%
- Volume
- 16.25K
- Avg volume
- 5.80K
- Open
- 0.0666
- Previous close
- 0.09
- Day's range
- 0.0666 – 0.10
- Beta
- 2.06
2Y -8,119.0250 (-100.00%)
Key statistics
- Enterprise value
- 19.47M
- PEG ratio
- 0.00
- Price / sales
- 31.06
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 133.30%
- Free cash flow
- 1.54M
- Total cash
- 33.00K
- Total debt
- 10.14M
- Return on equity
- 0.00%
- Short % of float
- 0.44%
- 50-day average
- 0.39948
- 200-day average
- 0.28671
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About FOXO Technologies Inc.
FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers. FOXO Technologies Inc. was founded in 2020 and is based in Minneapolis, Minnesota.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- foxotechnologies.com
News
FOXO TECHNOLOGIES INC.'S SUBSIDIARY VECTOR BIOSOURCE, INC. 
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS 
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT 
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY 
FOXO Technologies Inc. Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities 
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS 
FOXO Technologies Inc. Subsidiary, Myrtle Recovery Centers, Recognized by the Rural Health Association of Tennessee for Outstanding Community Impact 
FOXO TECHNOLOGIES INC. ANNOUNCES CLOSING OF VECTOR BIOSOURCE INC. 
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC. 
12 Information Technology Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on FOXO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DOWLING VINCENT J JR | Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 13, 2023 | 0 |
| KR8 AI INC | Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 21, 2024 | 0 |
| WARD MARTIN CHRISTOPHER | Chief Financial Officer | Sale | Jul 21, 2024 | 0 |
| WHITE MARK BRIAN | Chief Executive Officer | Sale | Jul 21, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Susquehanna International Group, LLP | 0.59% | 103,945 | 28.64K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.24% | 42,461 | 11.70K | Sep 29, 2024 |
| Virtu Financial LLC | 0.22% | 38,976 | 10.74K | Sep 29, 2024 |
| Corbin Capital Partners, LP | 0.16% | 27,480 | 7.57K | Sep 29, 2024 |
| Xtx Topco Ltd | 0.15% | 25,945 | 7.15K | Sep 29, 2024 |
| Vanguard Group Inc | 0.14% | 24,238 | 6.68K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.20% | 35,293 | 9.72K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.14% | 24,238 | 6.68K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.03% | 4,770 | 1.31K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 1,734 | 477 | Oct 30, 2024 |